Search

Your search keyword '"Riccio, Carmine"' showing total 161 results
Start Over Author "Riccio, Carmine" Search Limiters Full Text
161 results on '"Riccio, Carmine"'

1. Acute Coronary Syndrome in Elderly Patients: How to Tackle Them?

Author

Lucà, Fabiana, Andreotti, Felicita, Rao, Carmelo Massimiliano, Pelaggi, Giuseppe, Nucara, Mariacarmela, Ammendolea, Carlo, Pezzi, Laura, Ingianni, Nadia, Murrone, Adriano, Del Sindaco, Donatella, Lettino, Maddalena, Geraci, Giovanna, Riccio, Carmine, Bilato, Claudio, Colivicchi, Furio, Grimaldi, Massimo, Oliva, Fabrizio, Gulizia, Michele Massimo, and Parrini, Iris

Subjects
ST elevation myocardial infarction, MEDICAL personnel, OLDER patients, ACUTE coronary syndrome, OLDER people
Abstract

Elderly patients diagnosed with acute coronary syndromes (ACS) represent a growing demographic population. These patients typically present more comorbidities and experience poorer outcomes compared to younger patients. Furthermore, they are less frequently subjected to revascularization procedures and are less likely to receive evidence-based medications in both the short and long-term periods. Assessing frailty is crucial in elderly patients with ACS because it can influence management decisions, as well as risk stratification and prognosis. Indeed, treatment decisions should consider geriatric syndromes, frailty, polypharmacy, sarcopenia, nutritional deficits, prevalence of comorbidities, thrombotic risk, and, at the same time, an increased risk of bleeding. Rigorous clinical assessments, clear revascularization criteria, and tailored approaches to antithrombotic therapy are essential for guiding personalized treatment decisions in these individuals. Assessing frailty helps healthcare providers identify patients who may benefit from targeted interventions to improve their outcomes and quality of life. Elderly individuals who experience ACS remain significantly underrepresented and understudied in randomized controlled trials. For this reason, the occurrence of ACS in the elderly continues to be a particularly complex issue in clinical practice, and one that clinicians increasingly have to address, given the general ageing of populations. This review aims to address the complex aspects of elderly patients with ACS to help clinicians make therapeutic decisions when faced with such situations. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

2. Exploring the Perioperative Use of DOACs, off the Beaten Track

Author

Lucà, Fabiana, primary, Oliva, Fabrizio, additional, Giubilato, Simona, additional, Abrignani, Maurizio Giuseppe, additional, Rao, Carmelo Massimiliano, additional, Cornara, Stefano, additional, Caretta, Giorgio, additional, Di Fusco, Stefania Angela, additional, Ceravolo, Roberto, additional, Parrini, Iris, additional, Murrone, Adriano, additional, Geraci, Giovanna, additional, Riccio, Carmine, additional, Gelsomino, Sandro, additional, Colivicchi, Furio, additional, Grimaldi, Massimo, additional, and Gulizia, Michele Massimo, additional

Published
2024
Full Text
View/download PDF

3. Coagulation Tests and Reversal Agents in Patients Treated with Oral Anticoagulants: The Challenging Scenarios of Life-Threatening Bleeding and Unplanned Invasive Procedures

Author

Pozzi, Andrea, primary, Lucà, Fabiana, additional, Gelsomino, Sandro, additional, Abrignani, Maurizio Giuseppe, additional, Giubilato, Simona, additional, Di Fusco, Stefania Angela, additional, Rao, Carmelo Massimiliano, additional, Cornara, Stefano, additional, Caretta, Giorgio, additional, Ceravolo, Roberto, additional, Parrini, Iris, additional, Geraci, Giovanna, additional, Riccio, Carmine, additional, Grimaldi, Massimo, additional, Colivicchi, Furio, additional, Oliva, Fabrizio, additional, and Gulizia, Michele Massimo, additional

Published
2024
Full Text
View/download PDF

4. How to Manage Beta-Blockade in Older Heart Failure Patients: A Scoping Review

Author

Parrini, Iri, Lucà, Fabiana, Rao, Carmelo Massimiliano, Cacciatore, Stefano, Riccio, Carmine, Grimaldi, Massimo, Gulizia, Michele Massimo, Oliva, Fabrizio, Andreotti, Felicita, Andreotti, Felicita (ORCID:0000-0002-1456-6430), Parrini, Iri, Lucà, Fabiana, Rao, Carmelo Massimiliano, Cacciatore, Stefano, Riccio, Carmine, Grimaldi, Massimo, Gulizia, Michele Massimo, Oliva, Fabrizio, Andreotti, Felicita, and Andreotti, Felicita (ORCID:0000-0002-1456-6430)

Abstract

Beta blockers (BBs) play a crucial role in enhancing the quality of life and extending the survival of patients with heart failure and reduced ejection fraction (HFrEF). Initiating the therapy at low doses and gradually titrating the dose upwards is recommended to ensure therapeutic efficacy while mitigating potential adverse effects. Vigilant monitoring for signs of drug intolerance is necessary, with dose adjustments as required. The management of older HF patients requires a case-centered approach, taking into account individual comorbidities, functional status, and frailty. Older adults, however, are often underrepresented in randomized clinical trials, leading to some uncertainty in management strategies as patients with HF in clinical practice are older than those enrolled in trials. The present article performs a scoping review of the past 25 years of published literature on BBs in older HF patients, focusing on age, outcomes, and tolerability. Twelve studies (eight randomized-controlled and four observational) encompassing 26,426 patients were reviewed. The results indicate that BBs represent a viable treatment for older HFrEF patients, offering benefits in symptom management, cardiac function, and overall outcomes. Their role in HF with preserved EF, however, remains uncertain. Further research is warranted to refine treatment strategies and address specific aspects in older adults, including proper dosing, therapeutic adherence, and tolerability.

Published
2024

5. Takotsubo Syndrome and Gender Differences: Exploring Pathophysiological Mechanisms and Clinical Differences for a Personalized Approach in Patient Management.

Author

Giubilato, Simona, Francese, Giuseppina Maura, Manes, Maria Teresa, Rossini, Roberta, Della Bona, Roberta, Gatto, Laura, Di Monaco, Antonio, Zilio, Filippo, Gasparetto, Nicola, Sorini Dini, Carlotta, Borrello, Francesco, Mannarini, Antonia, Scardovi, Angela Beatrice, Pavan, Daniela, Amico, Francesco, Geraci, Giovanna, Riccio, Carmine, Colivicchi, Furio, Grimaldi, Massimo, and Gulizia, Michele Massimo

Subjects
TAKOTSUBO cardiomyopathy, SYMPATHETIC nervous system, ACUTE coronary syndrome, CORONARY artery disease, GENDER inequality
Abstract

Takotsubo syndrome (TTS), also known as the broken-heart syndrome, is a reversible condition typically observed in female patients presenting for acute coronary syndromes (ACS). Despite its increasing incidence, TTS often remains undiagnosed due to its overlap with ACS. The pathophysiology of TTS is complex and involves factors such as coronary vasospasm, microcirculatory dysfunction, increased catecholamine levels, and overactivity of the sympathetic nervous system. Diagnosing TTS requires a comprehensive approach, starting with clinical suspicion and progressing to both non-invasive and invasive multimodal tests guided by a specific diagnostic algorithm. Management of TTS should be personalized, considering potential complications, the presence or absence of coronary artery disease (CAD), diagnostic test results, and the patient's clinical course. The current data primarily derive from case series, retrospective analyses, prospective registries, and expert opinions. In recent years, there has been growing recognition of gender differences in the pathophysiology, presentation, and outcomes of TTS. This review provides an updated overview of gender disparities, highlighting the importance of tailored diagnostic and management strategies. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

6. Multidisciplinary Approach in Atrial Fibrillation: As Good as Gold.

Author

Lucà, Fabiana, Abrignani, Maurizio Giuseppe, Oliva, Fabrizio, Canale, Maria Laura, Parrini, Iris, Murrone, Adriano, Rao, Carmelo Massimiliano, Nesti, Martina, Cornara, Stefano, Di Matteo, Irene, Barisone, Michela, Giubilato, Simona, Ceravolo, Roberto, Pignalberi, Carlo, Geraci, Giovanna, Riccio, Carmine, Gelsomino, Sandro, Colivicchi, Furio, Grimaldi, Massimo, and Gulizia, Michele Massimo

Subjects
ATRIAL fibrillation, MEDICAL personnel, DISEASE progression, PATIENT care, CARDIOLOGISTS
Abstract

Atrial fibrillation (AF) represents the most common sustained arrhythmia necessitating dual focus: acute complication management and sustained longitudinal oversight to modulate disease progression and ensure comprehensive patient care over time. AF is a multifaceted disorder; due to such a great number of potential exacerbating conditions, a multidisciplinary team (MDT) should manage AF patients by cooperating with a cardiologist. Effective management of AF patients necessitates the implementation of a well-coordinated and tailored care pathway aimed at delivering optimized treatment through collaboration among various healthcare professionals. Management of AF should be carefully evaluated and mutually agreed upon in consultation with healthcare providers. It is crucial to recognize that treatment may evolve due to the emergence of new risk factors, symptoms, disease progression, and advancements in treatment modalities. In the context of multidisciplinary AF teams, a coordinated approach involves assembling a diverse team tailored to meet individual patients' unique needs based on local services' availability. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

7. A Comprehensive Geriatric Workup and Frailty Assessment in Older Patients with Severe Aortic Stenosis.

Author

Brunetti, Enrico, Lucà, Fabiana, Presta, Roberto, Marchionni, Niccolò, Boccanelli, Alessandro, Ungar, Andrea, Rao, Carmelo Massimiliano, Ingianni, Nadia, Lettino, Maddalena, Del Sindaco, Donatella, Murrone, Adriano, Riccio, Carmine, Colivicchi, Furio, Grimaldi, Massimo, Gulizia, Michele Massimo, Oliva, Fabrizio, Bo, Mario, and Parrini, Iris

Subjects
HEART valve prosthesis implantation, OLDER patients, OLDER people, AGE, AORTIC stenosis, GERIATRIC assessment
Abstract

Aortic stenosis (AS) represents a notable paradigm for cardiovascular (CV) and geriatric disorders owing to comorbidity. Transcatheter aortic valve replacement (TAVR) was initially considered a therapeutic strategy in elderly individuals deemed unsuitable for or at high risk of surgical valve replacement. The progressive improvement in TAVR technology has led to the need to refine older patients' stratification, progressively incorporating the concept of frailty and other geriatric vulnerabilities. Recognizing the intricate nature of the aging process, reliance exclusively on chronological age for stratification resulted in an initial but inadequate tool to assess both CV and non-CV risks effectively. A comprehensive geriatric evaluation should be performed before TAVR procedures, taking into account both physical and cognitive capabilities and post-procedural outcomes through a multidisciplinary framework. This review adopts a multidisciplinary perspective to delve into the diagnosis and holistic management of AS in elderly populations in order to facilitate decision-making, thereby optimizing outcomes centered around patient well-being. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

8. Aspirin in Primary Prevention: Looking for Those Who Enjoy It.

Author

Della Bona, Roberta, Giubilato, Simona, Palmieri, Marco, Benenati, Stefano, Rossini, Roberta, Di Fusco, Stefania Angela, Novarese, Filippo, Mascia, Giuseppe, Gasparetto, Nicola, Di Monaco, Antonio, Gatto, Laura, Zilio, Filippo, Sorini Dini, Carlotta, Borrello, Francesco, Geraci, Giovanna, Riccio, Carmine, De Luca, Leonardo, Colivicchi, Furio, Grimaldi, Massimo, and Giulizia, Michele Massimo

Subjects
ANTILIPEMIC agents, ASPIRIN, CANCER prevention, CARDIOVASCULAR diseases risk factors, DISEASE risk factors
Abstract

Based on a wealth of evidence, aspirin is one of the cornerstones of secondary prevention of cardiovascular disease. However, despite several studies showing efficacy also in primary prevention, an unopposed excess risk of bleeding leading to a very thin safety margin is evident in subjects without a clear acute cardiovascular event. Overall, the variability in recommendations from different scientific societies for aspirin use in primary prevention is a classic example of failure of simple risk stratification models based on competing risks (atherothrombosis vs. bleeding), perceived to be opposed but intertwined at the pathophysiological level. Notably, cardiovascular risk is dynamic in nature and cannot be accurately captured by scores, which do not always consider risk enhancers. Furthermore, the widespread use of other potent medications in primary prevention, such as lipid-lowering and anti-hypertensive drugs, might be reducing the benefit of aspirin in recent trials. Some authors, drawing from specific pathophysiological data, have suggested that specific subgroups might benefit more from aspirin. This includes patients with diabetes and those with obesity; sex-based differences are considered as well. Moreover, molecular analysis of platelet reactivity has been proposed. A beneficial effect of aspirin has also been demonstrated for the prevention of cancer, especially colorectal. This review explores evidence and controversies concerning the use of aspirin in primary prevention, considering new perspectives in order to provide a comprehensive individualized approach. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

9. Heart Failure with Preserved Ejection Fraction: How to Deal with This Chameleon

Author

Lucà, Fabiana, primary, Oliva, Fabrizio, additional, Abrignani, Maurizio Giuseppe, additional, Di Fusco, Stefania Angela, additional, Gori, Mauro, additional, Giubilato, Simona, additional, Ceravolo, Roberto, additional, Temporelli, Pier Luigi, additional, Cornara, Stefano, additional, Rao, Carmelo Massimiliano, additional, Caretta, Giorgio, additional, Pozzi, Andrea, additional, Binaghi, Giulio, additional, Maloberti, Alessandro, additional, Di Nora, Concetta, additional, Di Matteo, Irene, additional, Pilleri, Anna, additional, Gelsomino, Sandro, additional, Riccio, Carmine, additional, Grimaldi, Massimo, additional, Colivicchi, Furio, additional, and Gulizia, Michele Massimo, additional

Published
2024
Full Text
View/download PDF

10. How to Manage Beta-Blockade in Older Heart Failure Patients: A Scoping Review.

Author

Parrini, Iris, Lucà, Fabiana, Rao, Carmelo Massimiliano, Cacciatore, Stefano, Riccio, Carmine, Grimaldi, Massimo, Gulizia, Michele Massimo, Oliva, Fabrizio, and Andreotti, Felicita

Subjects
HEART failure patients, HEART failure, OLDER patients, OLDER people, CLINICAL trials, DRUG monitoring
Abstract

Beta blockers (BBs) play a crucial role in enhancing the quality of life and extending the survival of patients with heart failure and reduced ejection fraction (HFrEF). Initiating the therapy at low doses and gradually titrating the dose upwards is recommended to ensure therapeutic efficacy while mitigating potential adverse effects. Vigilant monitoring for signs of drug intolerance is necessary, with dose adjustments as required. The management of older HF patients requires a case-centered approach, taking into account individual comorbidities, functional status, and frailty. Older adults, however, are often underrepresented in randomized clinical trials, leading to some uncertainty in management strategies as patients with HF in clinical practice are older than those enrolled in trials. The present article performs a scoping review of the past 25 years of published literature on BBs in older HF patients, focusing on age, outcomes, and tolerability. Twelve studies (eight randomized-controlled and four observational) encompassing 26,426 patients were reviewed. The results indicate that BBs represent a viable treatment for older HFrEF patients, offering benefits in symptom management, cardiac function, and overall outcomes. Their role in HF with preserved EF, however, remains uncertain. Further research is warranted to refine treatment strategies and address specific aspects in older adults, including proper dosing, therapeutic adherence, and tolerability. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

11. The Challenge of Managing Atrial Fibrillation during Pregnancy

Author

Lucà, Fabiana, primary, Oliva, Fabrizio, primary, Abrignani, Maurizio Giuseppe, primary, Russo, Maria Giovanna, primary, Parrini, Iris, primary, Cornara, Stefano, primary, Ceravolo, Roberto, primary, Rao, Carmelo Massimiliano, primary, Favilli, Silvia, primary, Pozzi, Andrea, primary, Giubilato, Simona, primary, Di Fusco, Stefania Angela, primary, Sarubbi, Berardo, primary, Calvanese, Raimondo, primary, Chieffo, Alaide, primary, Gelsomino, Sandro, primary, Riccio, Carmine, primary, Grimaldi, Massimo, primary, Colivicchi, Furio, primary, and Gulizia, Michele Massimo, primary

Published
2023
Full Text
View/download PDF

12. The role of the pregnancy heart team in clinical practice

Author

Lucà, Fabiana, Colivicchi, Furio, Parrini, Iris, Russo, Maria Giovanna, Di Fusco, Stefania Angela, Ceravolo, Roberto, Riccio, Carmine, Favilli, Silvia, Rossini, Roberta, Gelsomino, Sandro, Oliva, Fabrizio, Gulizia, Michele Massimo, Lucà, Fabiana, Colivicchi, Furio, Parrini, Iri, Russo, Maria Giovanna, Di Fusco, Stefania Angela, Ceravolo, Roberto, Riccio, Carmine, Favilli, Silvia, Rossini, Roberta, Gelsomino, Sandro, Oliva, Fabrizio, and Gulizia, Michele Massimo

Subjects
postpartum followup, pre-conception counseling, corrected congenital heart disease, acquired heart disease, cardio obstetric team, pregnancy heart team, Cardiology and Cardiovascular Medicine, multidisciplinary team-Based approach
Abstract

Significant maternal and fetal morbidity and mortality risk has been shown to be associated with cardiovascular disease in pregnancy. Several determinants, such as the increasing number of females with corrected congenital heart disease in reproductive age, a more advanced maternal age associated with cardiovascular risk factors, and a greater prevalence of preexisting comorbidities related to cardiac disorders such as cancer and COVID-19), lead to a higher incidence of cardiac complications in pregnancy in the last few decades. However, adopting a multidisciplinary strategy may influence maternal and neonatal outcomes. This review aims at assessing the role of the Pregnancy Heart Team, which should ensure careful pre-pregnancy counseling, pregnancy monitoring, and delivery planning for both congenital and other cardiac or metabolic disorders, addressing several emerging aspects in the multidisciplinary team-based approach.

Published
2023
Full Text
View/download PDF

13. Management of Residual Risk in Chronic Coronary Syndromes. Clinical Pathways for a Quality-Based Secondary Prevention

Author

Giubilato, Simona, primary, Lucà, Fabiana, additional, Abrignani, Maurizio Giuseppe, additional, Gatto, Laura, additional, Rao, Carmelo Massimiliano, additional, Ingianni, Nadia, additional, Amico, Francesco, additional, Rossini, Roberta, additional, Caretta, Giorgio, additional, Cornara, Stefano, additional, Di Matteo, Irene, additional, Di Nora, Concetta, additional, Favilli, Silvia, additional, Pilleri, Anna, additional, Pozzi, Andrea, additional, Temporelli, Pier Luigi, additional, Zuin, Marco, additional, Amico, Antonio Francesco, additional, Riccio, Carmine, additional, Grimaldi, Massimo, additional, Colivicchi, Furio, additional, Oliva, Fabrizio, additional, and Gulizia, Michele Massimo, additional

Published
2023
Full Text
View/download PDF

14. Management of Patients Treated with Direct Oral Anticoagulants in Clinical Practice and Challenging Scenarios

Author

Lucà, Fabiana, primary, Oliva, Fabrizio, additional, Abrignani, Maurizio Giuseppe, additional, Di Fusco, Stefania Angela, additional, Parrini, Iris, additional, Canale, Maria Laura, additional, Giubilato, Simona, additional, Cornara, Stefano, additional, Nesti, Martina, additional, Rao, Carmelo Massimiliano, additional, Pozzi, Andrea, additional, Binaghi, Giulio, additional, Maloberti, Alessandro, additional, Ceravolo, Roberto, additional, Bisceglia, Irma, additional, Rossini, Roberta, additional, Temporelli, Pier Luigi, additional, Amico, Antonio Francesco, additional, Calvanese, Raimondo, additional, Gelsomino, Sandro, additional, Riccio, Carmine, additional, Grimaldi, Massimo, additional, Colivicchi, Furio, additional, and Gulizia, Michele Massimo, additional

Published
2023
Full Text
View/download PDF

15. Appropriateness of Dyslipidemia Management Strategies in Post-Acute Coronary Syndrome: A 2023 Update

Author

Lucà, Fabiana, primary, Oliva, Fabrizio, additional, Rao, Carmelo Massimiliano, additional, Abrignani, Maurizio Giuseppe, additional, Amico, Antonio Francesco, additional, Di Fusco, Stefania Angela, additional, Caretta, Giorgio, additional, Di Matteo, Irene, additional, Di Nora, Concetta, additional, Pilleri, Anna, additional, Ceravolo, Roberto, additional, Rossini, Roberta, additional, Riccio, Carmine, additional, Grimaldi, Massimo, additional, Colivicchi, Furio, additional, and Gulizia, Michele Massimo, additional

Published
2023
Full Text
View/download PDF

16. Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) scientific statement on the simplification of the drug regimen for secondary cardiovascular prevention

Author

De Luca, Leonardo, Di Fusco, Stefania Angela, Iannopollo, Gianmarco, Mistrulli, Raffaella, Rizzello, Vittoria, Aimo, Alberto, Navazio, Alessandro, Bilato, Claudio, Corda, Marco, Di Marco, Massimo, Geraci, Giovanna, Iacovoni, Attilio, Milli, Massimo, Pascale, Vittorio, Riccio, Carmine, Scicchitano, Pietro, Tizzani, Emanuele, Gabrielli, Domenico, Grimaldi, Massimo, Colivicchi, Furio, and Oliva, Fabrizio

Abstract

The issue of suboptimal drug regimen adherence in secondary cardiovascular prevention presents a significant barrier to improving patient outcomes. To address this, the utilization of drug combinations, specifically single pill combinations (SPCs) and polypills, was proposed as a strategy to simplify treatment regimens. This approach aims to enhance treatment accessibility, affordability, and adherence, thereby reducing healthcare costs and improving patient health. The document is an Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) scientific statement on simplifying drug regimens for secondary cardiovascular prevention. It discusses the underuse of treatments despite available, effective, and accessible options, highlighting a significant gap in secondary prevention across different socio-economic statuses and countries. The statement explores barriers to implementing evidence-based treatments, including patient, healthcare provider, and system-related challenges. The paper also reviews international guidelines, the role of SPCs and polypills in clinical practice, and their economic impact, advocating for their use in secondary prevention to improve patient outcomes and adherence.

Published
2024
Full Text
View/download PDF

17. Cardio-oncology rehabilitation: are we ready?

Author

Bisceglia, Irma, Venturini, Elio, Canale, Maria Laura, Ambrosetti, Marco, Riccio, Carmine, Giallauria, Francesco, Gallucci, Giuseppina, Abrignani, Maurizio G, Russo, Giulia, Lestuzzi, Chiara, Mistrulli, Raffaella, De Luca, Giovanni, Maria Turazza, Fabio, Mureddu, Gianfrancesco, Di Fusco, Stefania Angela, Lucà, Fabiana, De Luca, Leonardo, Camerini, Andrea, Halasz, Geza, Camilli, Massimiliano, Quagliariello, Vincenzo, Maurea, Nicola, Fattirolli, Francesco, Gulizia, Michele Massimo, Gabrielli, Domenico, Grimaldi, Massimo, Colivicchi, Furio, and Oliva, Fabrizio

Abstract

Cardio-oncology rehabilitation (CORE) is not only an essential component of cancer rehabilitation but also a pillar of preventive cardio-oncology. Cardio-oncology rehabilitation is a comprehensive model based on a multitargeted approach and its efficacy has been widely documented; when compared with an ‘exercise only’ programme, comprehensive CORE demonstrates a better outcome. It involves nutritional counselling, psychological support, and cardiovascular (CV) risk assessment, and it is directed to a very demanding population with a heavy burden of CV diseases driven by physical inactivity, cancer therapy-induced metabolic derangements, and cancer therapy-related CV toxicities. Despite its usefulness, CORE is still underused in cancer patients and we are still at the dawning of remote models of rehabilitation (tele-rehabilitation). Not all CORE is created equally: a careful screening procedure to identify patients who will benefit the most from CORE and a multidisciplinary customized approach are mandatory to achieve a better outcome for cancer survivors throughout their cancer journey. The aim of this paper is to provide an updated review of CORE not only for cardiologists dealing with this peculiar population of patients but also for oncologists, primary care providers, patients, and caregivers. This multidisciplinary team should help cancer patients to maintain a healthy and active life before, during, and after cancer treatment, in order to improve quality of life and to fight health inequities.

Published
2024
Full Text
View/download PDF

18. Italian Association of Hospital Cardiologists Position Paper ‘Gender discrepancy: time to implement gender-based clinical management’

Author

Lucà, Fabiana, Pavan, Daniela, Gulizia, Michele Massimo, Manes, Maria Teresa, Abrignani, Maurizio Giuseppe, Benedetto, Francesco Antonio, Bisceglia, Irma, Brigido, Silvana, Caldarola, Pasquale, Calvanese, Raimondo, Canale, Maria Laura, Caretta, Giorgio, Ceravolo, Roberto, Chieffo, Alaide, Chimenti, Cristina, Cornara, Stefano, Cutolo, Ada, Di Fusco, Stefania Angela, Di Matteo, Irene, Di Nora, Concetta, Fattirolli, Francesco, Favilli, Silvia, Francese, Giuseppina Maura, Gelsomino, Sandro, Geraci, Giovanna, Giubilato, Simona, Ingianni, Nadia, Iorio, Annamaria, Lanni, Francesca, Montalto, Andrea, Nardi, Federico, Navazio, Alessandro, Nesti, Martina, Parrini, Iris, Pilleri, Annarita, Pozzi, Andrea, Rao, Carmelo Massimiliano, Riccio, Carmine, Rossini, Roberta, Scicchitano, Pietro, Valente, Serafina, Zuccalà, Giuseppe, Gabrielli, Domenico, Grimaldi, Massimo, Colivicchi, Furio, and Oliva, Fabrizio

Abstract

It has been well assessed that women have been widely under-represented in cardiovascular clinical trials. Moreover, a significant discrepancy in pharmacological and interventional strategies has been reported. Therefore, poor outcomes and more significant mortality have been shown in many diseases. Pharmacokinetic and pharmacodynamic differences in drug metabolism have also been described so that effectiveness could be different according to sex. However, awareness about the gender gap remains too scarce. Consequently, gender-specific guidelines are lacking, and the need for a sex-specific approach has become more evident in the last few years. This paper aims to evaluate different therapeutic approaches to managing the most common women’s diseases.

Published
2024
Full Text
View/download PDF

19. Italian Association of Hospital Cardiologists position paper—obesity in adults: a clinical primer

Author

Di Fusco, Stefania Angela, Mocini, Edoardo, Gori, Mauro, Iacoviello, Massimo, Bilato, Claudio, Corda, Marco, De Luca, Leonardo, Di Marco, Massimo, Geraci, Giovanna, Iacovoni, Attilio, Milli, Massimo, Navazio, Alessandro, Pascale, Vittorio, Riccio, Carmine, Scicchitano, Pietro, Tizzani, Emanuele, Gabrielli, Domenico, Grimaldi, Massimo, Colivicchi, Furio, and Oliva, Fabrizio

Abstract

Obesity is a chronic and relapsing disease characterized by the interaction between individual predispositions and an obesogenic environment. Recent advances in understanding the mechanisms of energetic homoeostasis paved the way to more effective therapeutic approaches compared with traditional treatments. Since obesity is a complex disease, it necessitates a multi-disciplinary approach whose implementation remains challenging. Nonetheless, emerging pharmacological interventions appear promising. Currently, therapeutic success is discreet in the short term but often fails to maintain long-term weight loss due to a high likelihood of weight regain. Cardiologists play a key role in managing patients with obesity, yet often lack familiarity with its comprehensive management. The aim of this document is to summarize knowledge to consolidate essential knowledge for clinicians to effectively treat patients living with obesity. The paper emphasizes the pivotal role of a strong patient–clinician relationship in navigating successful treatment. We analyse the criteria commonly used to diagnose obesity and point out the strengths and limitations of different criteria. Furthermore, we discuss the role of obesiologists and the contributions of cardiologists. In addition, we detail key components of effective therapeutic strategies, including educational aspects and pharmacological options.

Published
2024
Full Text
View/download PDF

20. Anderson–Fabry Disease: Red Flags for Early Diagnosis of Cardiac Involvement.

Author

Iorio, Annamaria, Lucà, Fabiana, Pozzi, Andrea, Rao, Carmelo Massimiliano, Chimenti, Cristina, Di Fusco, Stefania Angela, Rossini, Roberta, Caretta, Giorgio, Cornara, Stefano, Giubilato, Simona, Di Matteo, Irene, Di Nora, Concetta, Pilleri, Anna, Gelsomino, Sandro, Ceravolo, Roberto, Riccio, Carmine, Grimaldi, Massimo, Colivicchi, Furio, Oliva, Fabrizio, and Gulizia, Michele Massimo

Subjects
ANGIOKERATOMA corporis diffusum, ARRHYTHMIA, LEFT ventricular hypertrophy, EARLY diagnosis, SUDDEN death, GENETIC testing
Abstract

Anderson–Fabry disease (AFD) is a lysosome storage disorder resulting from an X-linked inheritance of a mutation in the galactosidase A (GLA) gene encoding for the enzyme alpha-galactosidase A (α-GAL A). This mutation results in a deficiency or absence of α-GAL A activity, with a progressive intracellular deposition of glycosphingolipids leading to organ dysfunction and failure. Cardiac damage starts early in life, often occurring sub-clinically before overt cardiac symptoms. Left ventricular hypertrophy represents a common cardiac manifestation, albeit conduction system impairment, arrhythmias, and valvular abnormalities may also characterize AFD. Even in consideration of pleiotropic manifestation, diagnosis is often challenging. Thus, knowledge of cardiac and extracardiac diagnostic "red flags" is needed to guide a timely diagnosis. Indeed, considering its systemic involvement, a multidisciplinary approach may be helpful in discerning AFD-related cardiac disease. Beyond clinical pearls, a practical approach to assist clinicians in diagnosing AFD includes optimal management of biochemical tests, genetic tests, and cardiac biopsy. We extensively reviewed the current literature on AFD cardiomyopathy, focusing on cardiac "red flags" that may represent key diagnostic tools to establish a timely diagnosis. Furthermore, clinical findings to identify patients at higher risk of sudden death are also highlighted. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

21. Management of oral anticoagulant therapy after intracranial hemorrhage in patients with atrial fibrillation

Author

Lucà, Fabiana, primary, Colivicchi, Furio, additional, Oliva, Fabrizio, additional, Abrignani, Maurizio, additional, Caretta, Giorgio, additional, Di Fusco, Stefania Angela, additional, Giubilato, Simona, additional, Cornara, Stefano, additional, Di Nora, Concetta, additional, Pozzi, Andrea, additional, Di Matteo, Irene, additional, Pilleri, Anna, additional, Rao, Carmelo Massimiliano, additional, Parlavecchio, Antonio, additional, Ceravolo, Roberto, additional, Benedetto, Francesco Antonio, additional, Rossini, Roberta, additional, Calvanese, Raimondo, additional, Gelsomino, Sandro, additional, Riccio, Carmine, additional, and Gulizia, Michele Massimo, additional

Published
2023
Full Text
View/download PDF

22. ANMCO-SIMEU consensus document: appropriate management of atrial fibrillation in the emergency department

Author

Caldarola, Pasquale, primary, De Iaco, Fabio, additional, Pugliese, Francesco Rocco, additional, De Luca, Leonardo, additional, Fabbri, Andrea, additional, Riccio, Carmine, additional, Scicchitano, Pietro, additional, Vanni, Simone, additional, Di Pasquale, Giuseppe, additional, Gulizia, Michele Massimo, additional, Gabrielli, Domenico, additional, Oliva, Fabrizio, additional, and Colivicchi, Furio, additional

Published
2023
Full Text
View/download PDF

23. ANMCO position paper on the management of hypercholesterolaemia in patients with acute coronary syndrome

Author

De Luca, Leonardo, primary, Riccio, Carmine, additional, Navazio, Alessandro, additional, Valente, Serafina, additional, Cipriani, Manlio, additional, Corda, Marco, additional, De Nardo, Alfredo, additional, Francese, Giuseppina Maura, additional, Napoletano, Cosimo, additional, Tizzani, Emanuele, additional, Roncon, Loris, additional, Caldarola, Pasquale, additional, Gulizia, Michele Massimo, additional, Gabrielli, Domenico, additional, Oliva, Fabrizio, additional, and Colivicchi, Furio, additional

Published
2023
Full Text
View/download PDF

24. Patent Foramen Ovale and Cryptogenic Stroke: Integrated Management

Author

Lucà, Fabiana, primary, Pino, Paolo G., additional, Parrini, Iris, additional, Di Fusco, Stefania Angela, additional, Ceravolo, Roberto, additional, Madeo, Andrea, additional, Leone, Angelo, additional, La Mair, Mark, additional, Benedetto, Francesco Antonio, additional, Riccio, Carmine, additional, Oliva, Fabrizio, additional, Colivicchi, Furio, additional, Gulizia, Michele Massimo, additional, and Gelsomino, Sandro, additional

Published
2023
Full Text
View/download PDF

25. A Tailored Antithrombotic Approach for Patients with Atrial Fibrillation Presenting with Acute Coronary Syndrome and/or Undergoing PCI: A Case Series

Author

Giubilato, Simona, primary, Lucà, Fabiana, additional, Pozzi, Andrea, additional, Caretta, Giorgio, additional, Cornara, Stefano, additional, Pilleri, Anna, additional, Di Nora, Concetta, additional, Amico, Francesco, additional, Di Matteo, Irene, additional, Favilli, Silvia, additional, Rossini, Roberta, additional, Riccio, Carmine, additional, Colivicchi, Furio, additional, and Gulizia, Michele Massimo, additional

Published
2022
Full Text
View/download PDF

27. ANMCO statement on the use of sodium-glucose cotransporter 2 inhibitors in patients with heart failure: a practical guide for a streamlined implementation

Author

Di Fusco, Stefania Angela, primary, Gronda, Edoardo, additional, Mocini, Edoardo, additional, Lucà, Fabiana, additional, Bisceglia, Irma, additional, De Luca, Leonardo, additional, Caldarola, Pasquale, additional, Cipriani, Manlio, additional, Corda, Marco, additional, De Nardo, Alfredo, additional, Francese, Giuseppina Maura, additional, Napoletano, Cosimo, additional, Navazio, Alessandro, additional, Riccio, Carmine, additional, Roncon, Loris, additional, Tizzani, Emanuele, additional, Nardi, Federico, additional, Urbinati, Stefano, additional, Valente, Serafina, additional, Gulizia, Michele Massimo, additional, Gabrielli, Domenico, additional, Oliva, Fabrizio, additional, Imperoli, Giuseppe, additional, and Colivicchi, Furio, additional

Published
2022
Full Text
View/download PDF

28. ANMCO position paper on antithrombotic treatment of patients with atrial fibrillation undergoing intracoronary stenting and/or acute coronary syndromes

Author

De Luca, Leonardo, primary, Rubboli, Andrea, additional, Lettino, Maddalena, additional, Tubaro, Marco, additional, Leonardi, Sergio, additional, Casella, Gianni, additional, Valente, Serafina, additional, Rossini, Roberta, additional, Sciahbasi, Alessandro, additional, Natale, Enrico, additional, Trambaiolo, Paolo, additional, Navazio, Alessandro, additional, Cipriani, Manlio, additional, Corda, Marco, additional, De Nardo, Alfredo, additional, Francese, Giuseppina Maura, additional, Napoletano, Cosimo, additional, Tizzani, Emanuele, additional, Nardi, Federico, additional, Roncon, Loris, additional, Caldarola, Pasquale, additional, Riccio, Carmine, additional, Gabrielli, Domenico, additional, Oliva, Fabrizio, additional, Massimo Gulizia, Michele, additional, and Colivicchi, Furio, additional

Published
2022
Full Text
View/download PDF

29. ANMCO position paper: 2022 focused update of appropriate use criteria for multimodality imaging: aortic valve disease

Author

Nardi, Federico, primary, Pino, Paolo Giuseppe, additional, De Luca, Leonardo, additional, Riccio, Carmine, additional, Cipriani, Manlio, additional, Corda, Marco, additional, Francese, Giuseppina Maura, additional, Gabrielli, Domenico, additional, Oliva, Fabrizio, additional, Gulizia, Michele Massimo, additional, and Colivicchi, Furio, additional

Published
2022
Full Text
View/download PDF

30. ANMCO position paper ‘Appropriateness of prescribing direct oral anticoagulants in stroke and systemic thromboembolism prevention in adult patients with non-valvular atrial fibrillation’

Author

Mocini, David, primary, Di Fusco, Stefania Angela, additional, De Luca, Leonardo, additional, Caldarola, Pasquale, additional, Cipriani, Manlio, additional, Corda, Marco, additional, Di Lenarda, Andrea, additional, De Nardo, Alfredo, additional, Francese, Giuseppina Maura, additional, Napoletano, Cosimo, additional, Navazio, Alessandro, additional, Riccio, Carmine, additional, Roncon, Loris, additional, Tizzani, Emanuele, additional, Nardi, Federico, additional, Urbinati, Stefano, additional, Valente, Serafina, additional, Gulizia, Michele Massimo, additional, Gabrielli, Domenico, additional, Oliva, Fabrizio, additional, and Colivicchi, Furio, additional

Published
2022
Full Text
View/download PDF

31. Management of Acute Coronary Syndrome in Cancer Patients: It’s High Time We Dealt with It

Author

Lucà, Fabiana, primary, Parrini, Iris, additional, Abrignani, Maurizio Giuseppe, additional, Rao, Carmelo Massimiliano, additional, Piccioni, Laura, additional, Di Fusco, Stefania Angela, additional, Ceravolo, Roberto, additional, Bisceglia, Irma, additional, Riccio, Carmine, additional, Gelsomino, Sandro, additional, Colivicchi, Furio, additional, and Gulizia, Michele Massimo, additional

Published
2022
Full Text
View/download PDF

32. Update on Management of Cardiovascular Diseases in Women

Author

Lucà, Fabiana, primary, Abrignani, Maurizio Giuseppe, additional, Parrini, Iris, additional, Di Fusco, Stefania Angela, additional, Giubilato, Simona, additional, Rao, Carmelo Massimiliano, additional, Piccioni, Laura, additional, Cipolletta, Laura, additional, Passaretti, Bruno, additional, Giallauria, Francesco, additional, Leone, Angelo, additional, Francese, Giuseppina Maura, additional, Riccio, Carmine, additional, Gelsomino, Sandro, additional, Colivicchi, Furio, additional, and Gulizia, Michele Massimo, additional

Published
2022
Full Text
View/download PDF

33. Direct Oral Anticoagulants in Patients with Obesity and Atrial Fibrillation: Position Paper of Italian National Association of Hospital Cardiologists (ANMCO)

Author

Mocini, David, primary, Di Fusco, Stefania Angela, additional, Mocini, Edoardo, additional, Donini, Lorenzo Maria, additional, Lavalle, Carlo, additional, Di Lenarda, Andrea, additional, Riccio, Carmine, additional, Caldarola, Pasquale, additional, De Luca, Leonardo, additional, Gulizia, Michele Massimo, additional, Oliva, Fabrizio, additional, Gabrielli, Domenico, additional, and Colivicchi, Furio, additional

Published
2021
Full Text
View/download PDF

35. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes

Author

Neumann, Franz Josef, Sechtem, Udo, Banning, Adrian Paul, Bonaros, Nikolaos, Bueno, Héctor, Bugiardini, Raffaele, Chieffo, Alaide, Crea, Filippo, Czerny, Martin, Delgado, Victoria, Dendale, Paul, Knuuti, Juhani, Wijns, William, Flachskampf, Frank Arnold, Gohlke, Helmut, Grove, Erik Lerkevang, James, Stefan, Katritsis, Demosthenes, Landmesser, Ulf, Lettino, Maddalena, Matter, Christian M., Nathoe, Hendrik, Niessner, Alexander, Patrono, Carlo, Petronio, Anna Sonia, Pettersen, Steffen E., Piccolo, Raffaele, Piepoli, Massimo Francesco, Popescu, Bogdan A., Räber, Lorenz, Richter, Dimitrios J., Roffi, Marco, Roithinger, Franz X., Shlyakhto, Evgeny, Sibbing, Dirk, Silber, Sigmund, Simpson, Iain A., Sousa-Uva, Miguel, Vardas, Panos, Witkowski, Adam, Zamorano, Jose Luis, Achenbach, Stephan, Agewall, Stefan, Barbato, Emanuele, Bax, Jeroen J., Capodanno, Davide, Cuisset, Thomas, Deaton, Christi, Dickstein, Kenneth, Edvardsen, Thor, Escaned, Javier, Funck-Brentano, Christian, Gersh, Bernard J., Gilard, Martine, Hasdai, David, Hatala, Robert, Mahfoud, Felix, Masip, Josep, Muneretto, Claudio, Prescott, Eva, Saraste, Antti, Storey, Robert F., Svitil, Pavel, Valgimigli, Marco, Aboyans, Victor, Baigent, Colin, Collet, Jean Philippe, Dean, Veronica, Fitzsimons, Donna, Gale, Christopher P., Grobbee, Diederick E., Halvorsen, Sigrun, Hindricks, Gerhard, Iung, Bernard, Jüni, Peter, Katus, Hugo A., Leclercq, Christophe, Lewis, Basil S., Merkely, Bela, Mueller, Christian, Petersen, Steffen, Touyz, Rhian M., Benkhedda, Salim, Metzler, Bernhard, Sujayeva, Volha, Cosyns, Bernard, Kusljugic, Zumreta, Velchev, Vasil, Panayi, Georgios, Kala, Petr, Haahr-Pedersen, Sune Ammentorp, Kabil, Hamza, Ainla, Tiia, Kaukonen, Tomi, Cayla, Guillaume, Pagava, Zurab, Woehrle, Jochen, Kanakakis, John, Toth, Kalman, Gudnason, Thorarinn, Peace, Aaron, Aronson, Doron, Riccio, Carmine, Elezi, Shpend, Mirrakhimov, Erkin, Hansone, Silvija, Sarkis, Antoine, Babarskiene, Ruta, Beissel, Jean, Cassar Maempel, Andrew J., Revenco, Valeriu, de Grooth, G. J., Pejkov, Hristo, Juliebø, Vibeke, Lipiec, Piotr, Santos, Jose, Chioncel, Ovidiu, Duplyakov, Dmitry, Bertelli, Luca, Dikic, Ana Djordjevic, Studencan, Martin, Bunc, Matjaz, Alfonso, Fernando, Back, Magnus, Zellweger, Michael, Addad, Faouzi, Yildirir, Aylin, Sirenko, Yuriy, Clapp, Brian, Neumann, Franz Josef, Sechtem, Udo, Banning, Adrian Paul, Bonaros, Nikolaos, Bueno, Héctor, Bugiardini, Raffaele, Chieffo, Alaide, Crea, Filippo, Czerny, Martin, Delgado, Victoria, Dendale, Paul, Knuuti, Juhani, Wijns, William, Flachskampf, Frank Arnold, Gohlke, Helmut, Grove, Erik Lerkevang, James, Stefan, Katritsis, Demosthenes, Landmesser, Ulf, Lettino, Maddalena, Matter, Christian M., Nathoe, Hendrik, Niessner, Alexander, Patrono, Carlo, Petronio, Anna Sonia, Pettersen, Steffen E., Piccolo, Raffaele, Piepoli, Massimo Francesco, Popescu, Bogdan A., Räber, Lorenz, Richter, Dimitrios J., Roffi, Marco, Roithinger, Franz X., Shlyakhto, Evgeny, Sibbing, Dirk, Silber, Sigmund, Simpson, Iain A., Sousa-Uva, Miguel, Vardas, Panos, Witkowski, Adam, Zamorano, Jose Luis, Achenbach, Stephan, Agewall, Stefan, Barbato, Emanuele, Bax, Jeroen J., Capodanno, Davide, Cuisset, Thomas, Deaton, Christi, Dickstein, Kenneth, Edvardsen, Thor, Escaned, Javier, Funck-Brentano, Christian, Gersh, Bernard J., Gilard, Martine, Hasdai, David, Hatala, Robert, Mahfoud, Felix, Masip, Josep, Muneretto, Claudio, Prescott, Eva, Saraste, Antti, Storey, Robert F., Svitil, Pavel, Valgimigli, Marco, Aboyans, Victor, Baigent, Colin, Collet, Jean Philippe, Dean, Veronica, Fitzsimons, Donna, Gale, Christopher P., Grobbee, Diederick E., Halvorsen, Sigrun, Hindricks, Gerhard, Iung, Bernard, Jüni, Peter, Katus, Hugo A., Leclercq, Christophe, Lewis, Basil S., Merkely, Bela, Mueller, Christian, Petersen, Steffen, Touyz, Rhian M., Benkhedda, Salim, Metzler, Bernhard, Sujayeva, Volha, Cosyns, Bernard, Kusljugic, Zumreta, Velchev, Vasil, Panayi, Georgios, Kala, Petr, Haahr-Pedersen, Sune Ammentorp, Kabil, Hamza, Ainla, Tiia, Kaukonen, Tomi, Cayla, Guillaume, Pagava, Zurab, Woehrle, Jochen, Kanakakis, John, Toth, Kalman, Gudnason, Thorarinn, Peace, Aaron, Aronson, Doron, Riccio, Carmine, Elezi, Shpend, Mirrakhimov, Erkin, Hansone, Silvija, Sarkis, Antoine, Babarskiene, Ruta, Beissel, Jean, Cassar Maempel, Andrew J., Revenco, Valeriu, de Grooth, G. J., Pejkov, Hristo, Juliebø, Vibeke, Lipiec, Piotr, Santos, Jose, Chioncel, Ovidiu, Duplyakov, Dmitry, Bertelli, Luca, Dikic, Ana Djordjevic, Studencan, Martin, Bunc, Matjaz, Alfonso, Fernando, Back, Magnus, Zellweger, Michael, Addad, Faouzi, Yildirir, Aylin, Sirenko, Yuriy, and Clapp, Brian

Abstract

Coronary artery disease (CAD) is a pathological process characterized by atherosclerotic plaque accumulation in the epicardial arteries, whether obstructive or non-obstructive. This process can be modified by lifestyle adjustments, pharmacological therapies, and invasive interventions designed to achieve disease stabilization or regression. The disease can have long, stable periods but can also become unstable at any time, typically due to an acute atherothrombotic event caused by plaque rupture or erosion. However, the disease is chronic, most often progressive, and hence serious, even in clinically apparently silent periods. The dynamic nature of the CAD process results in various clinical presentations, which can be conveniently categorized as either acute coronary syndromes (ACS) or chronic coronary syndromes (CCS). The Guidelines presented here refer to the management of patients with CCS. The natural history of CCS is illustrated in Figure 1.

Published
2020

36. Cardiac Prevention and Rehabilitation “3.0”: From acute to chronic phase. Position Paper of the ltalian Association for Cardiovascular Prevention and Rehabilitation (GICR-IACPR)

Author

Pedretti, Roberto F.E., primary, Fattirolli, Francesco, additional, Griffo, Raffaele, additional, Ambrosetti, Marco, additional, Angelino, Elisabetta, additional, Brazzo, Silvia, additional, Corrà, Ugo, additional, Dasseni, Nicolò, additional, Faggiano, Pompilio, additional, Favretto, Giuseppe, additional, Febo, Oreste, additional, Ferrari, Marina, additional, Giallauria, Francesco, additional, Greco, Cesare, additional, Iannucci, Manuela, additional, La Rovere, Maria Teresa, additional, Mallardo, Mario, additional, Mazza, Antonio, additional, Piepoli, Massimo, additional, Riccio, Carmine, additional, Scalvini, Simonetta, additional, Tavazzi, Luigi, additional, Temporelli, Pier Luigi, additional, and Mureddu, Gian Francesco, additional

Published
2018
Full Text
View/download PDF

37. ANMCO/ISS/AMD/ANCE/ARCA/FADOI/GICR-IACPR/SICI-GISE/SIBioC/SIC/SICOA/SID/SIF/SIMEU/SIMG/SIMI/SISA Joint Consensus Document on cholesterol and cardiovascular risk: diagnostic–therapeutic pathway in Italy

Author

Gulizia, Michele Massimo, primary, Colivicchi, Furio, additional, Ricciardi, Gualtiero, additional, Giampaoli, Simona, additional, Maggioni, Aldo Pietro, additional, Averna, Maurizio, additional, Graziani, Maria Stella, additional, Ceriotti, Ferruccio, additional, Mugelli, Alessandro, additional, Rossi, Francesco, additional, Medea, Gerardo, additional, Parretti, Damiano, additional, Abrignani, Maurizio Giuseppe, additional, Arca, Marcello, additional, Perrone Filardi, Pasquale, additional, Perticone, Francesco, additional, Catapano, Alberico, additional, Griffo, Raffaele, additional, Nardi, Federico, additional, Riccio, Carmine, additional, Di Lenarda, Andrea, additional, Scherillo, Marino, additional, Musacchio, Nicoletta, additional, Panno, Antonio Vittorio, additional, Zito, Giovanni Battista, additional, Campanini, Mauro, additional, Bolognese, Leonardo, additional, Faggiano, Pompilio Massimo, additional, Musumeci, Giuseppe, additional, Pusineri, Enrico, additional, Ciaccio, Marcello, additional, Bonora, Enzo, additional, Cantelli Forti, Giorgio, additional, Ruggieri, Maria Pia, additional, Cricelli, Claudio, additional, Romeo, Francesco, additional, Ferrari, Roberto, additional, and Maseri, Attilio, additional

Published
2017
Full Text
View/download PDF

38. ANMCO Position Paper: direct oral anticoagulants for stroke prevention in atrial fibrillation: clinical scenarios and future perspectives

Author

Nardi, Federico, primary, Gulizia, Michele Massimo, additional, Colivicchi, Furio, additional, Abrignani, Maurizio Giuseppe, additional, Di Fusco, Stefania Angela, additional, Di Lenarda, Andrea, additional, Di Tano, Giuseppe, additional, Geraci, Giovanna, additional, Moschini, Luigi, additional, Riccio, Carmine, additional, Verdecchia, Paolo, additional, and Enea, Iolanda, additional

Published
2017
Full Text
View/download PDF

39. ANMCO Position Paper: hospital discharge planning: recommendations and standards

Author

Mennuni, Mauro, primary, Gulizia, Michele Massimo, additional, Alunni, Gianfranco, additional, Francesco Amico, Antonio, additional, Maria Bovenzi, Francesco, additional, Caporale, Roberto, additional, Colivicchi, Furio, additional, Di Lenarda, Andrea, additional, Di Tano, Giuseppe, additional, Egman, Sabrina, additional, Fattirolli, Francesco, additional, Gabrielli, Domenico, additional, Geraci, Giovanna, additional, Gregorio, Giovanni, additional, Francesco Mureddu, Gian, additional, Nardi, Federico, additional, Radini, Donatella, additional, Riccio, Carmine, additional, Rigo, Fausto, additional, Sicuro, Marco, additional, Urbinati, Stefano, additional, and Zuin, Guerrino, additional

Published
2017
Full Text
View/download PDF

42. Acute myocardial infarction in the elderly. A case-control study with a younger population and review of literature

Author

Corsini, Fabrizio, primary, Scaglione, Anna, additional, Iacomino, Maria, additional, Mascia, Giuseppe, additional, Melorio, Saverio, additional, Riccio, Carmine, additional, Romano, Salvatore, additional, Vetrano, Alfredo, additional, Celardo, Silvana, additional, Corsini, Giancarlo, additional, and Chieffo, Carmelo, additional

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results